Your browser doesn't support javascript.
loading
Minimizing risk while maximizing opportunity: The infectious disease organ offer process survey.
Prakash, Katya; Saharia, Kapil K; Karaba, Andrew; Law, Nancy; Albarillo, Fritzie S; Zangeneh, Tirdad T; Grossi, Paolo; Miller, Rachel; Slavin, Monica; Shoham, Shmuel; Ison, Michael; La Hoz, Ricardo M; Baddley, John W.
Afiliação
  • Prakash K; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Saharia KK; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Karaba A; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Law N; University of California San Diego School of Medicine, San Diego, California, USA.
  • Albarillo FS; Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.
  • Zangeneh TT; University of Arizona College of Medicine, Tucson, Arizona, USA.
  • Grossi P; Duke University School of Medicine, Varese, Italy.
  • Miller R; School of Medicine, Duke University, Durham, North Carolina, USA.
  • Slavin M; Peter MacCallum Cancer Center, University of Melbourne, Melbourne, Australia.
  • Shoham S; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Ison M; National Institutes of Health, Bethesda, Maryland, USA.
  • La Hoz RM; Division of Infectious Disease, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Baddley JW; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Transpl Infect Dis ; : e14342, 2024 Jul 22.
Article em En | MEDLINE | ID: mdl-39037217
ABSTRACT

BACKGROUND:

The purpose of this study was to understand how transplant infectious disease (TID) physicians assess a potential donor with known or suspected infection and describe posttransplant management.

METHODS:

We designed a survey of 10 organ offer scenarios and asked questions pertaining to organ acceptability for transplantation and management posttransplant. The survey was distributed to TID clinicians via transplant society listservs and email. Responses were recorded in REDCap, and descriptive statistics were employed.

RESULTS:

One hundred thirteen infectious disease physicians responded to the survey, of whom 85 completed all cases. Respondents were generally in agreement regarding organ acceptability, although some divergence was seen when evaluating lungs from donors with influenza, tuberculosis, or multidrug-resistant Acinetobacter infection. Posttransplant management showed more variation. Areas of optimization were identified (1) Further understanding of where risk-mitigation strategies within the donor offer process may improve donor acceptability and therefore organ utilization; (2) importance of recipient considerations in assessing degree of infectious risk; and (3) gaps in evidenced-based data regarding optimal posttransplant management of recipients.

CONCLUSION:

Evaluation of donor offers by TID clinicians is a complex process. Although the survey does not itself serve to make recommendations regarding best practices, it highlights areas where generation of data to inform acceptance and management practices may allow for improved organ utilization and recipient management.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article